AMRN logo

Amarin Corp Plc

AMRN

AMRN: Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its lead product includes Vascepa.

more

Show AMRN Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of AMRN by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by AMRN's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $30,000 Apr 18, 2022 Issue: Health Issues
  • $30,000 Jan 20, 2022 Issue: Health Issues
  • $70,000 Jan 09, 2022 Issue: Health Issues
  • $30,000 Oct 20, 2021 Issue: Health Issues
  • $70,000 Oct 16, 2021 Issue: Health Issues
  • $30,000 Jul 20, 2021 Issue: Health Issues
  • $80,000 Jul 19, 2021 Issue: Health Issues
  • $30,000 Apr 20, 2021 Issue: Health Issues
  • $70,000 Apr 19, 2021 Issue: Health Issues
  • $30,000 Jan 21, 2021 Issue: Health Issues
  • $80,000 Jan 13, 2021 Issue: Health Issues
  • $30,000 Oct 20, 2020 Issue: Health Issues
  • $80,000 Oct 16, 2020 Issue: Health Issues
  • $30,000 Jul 20, 2020 Issue: Health Issues
  • $80,000 Jul 16, 2020 Issue: Health Issues
  • $60,000 Apr 20, 2020 Issue: Health Issues
  • $80,000 Apr 18, 2020 Issue: Health Issues
  • $80,000 Apr 22, 2019 Issue: Health Issues
  • $30,000 Jan 22, 2019 Issue: Health Issues
  • $110,000 Jul 20, 2018 Issue: Health Issues
  • $40,000 Apr 19, 2018 Issue: Health Issues
  • $30,000 Jul 20, 2015 Issue: Insurance
  • $40,000 Apr 20, 2015 Issue: Insurance
  • $20,000 Oct 20, 2014 Issue: Health Issues
  • $20,000 Oct 18, 2014 Issue: Health Issues Budget/Appropriations
  • $40,000 Oct 17, 2014 Issue: Health Issues
  • $90,000 Jul 21, 2014 Issue: Health Issues
  • $80,000 Jul 21, 2014 Issue: Health Issues
  • $30,000 Jul 19, 2014 Issue: Budget/Appropriations Health Issues
  • $60,000 Jul 09, 2014 Issue: Health Issues
  • $130,000 Apr 16, 2014 Issue: Health Issues
  • $130,000 Apr 15, 2014 Issue: Health Issues
  • $160,000 Apr 09, 2014 Issue: Health Issues
  • $150,000 Jan 21, 2014 Issue: Health Issues
  • $150,000 Jan 21, 2014 Issue: Health Issues
  • $120,000 Jan 12, 2014 Issue: Health Issues
  • $10,000 Jul 29, 2013 Issue: Energy/Nuclear
  • $10,000 Jul 10, 2012 Issue: Energy/Nuclear
  • $10,000 Jan 13, 2012 Issue: Energy/Nuclear
  • $20,000 Oct 18, 2011 Issue: Energy/Nuclear
  • $20,000 Jul 14, 2011 Issue: Energy/Nuclear
  • $10,000 Apr 11, 2011 Issue: Energy/Nuclear
  • $20,000 Oct 13, 2010 Issue: Energy/Nuclear
  • $20,000 Jul 15, 2010 Issue: Energy/Nuclear
  • $20,000 Apr 13, 2010 Issue: Energy/Nuclear
U.S. Patents

New patents grants

  • Patent Title: Highly purified ethyl epa and other epa derivatives May. 29, 2012
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of AMRN in WallStreetBets Daily Discussion

AMRN News

Recent insights relating to AMRN

CNBC Recommendations

Recent picks made for AMRN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AMRN

Corporate Flights

Flights by private jets registered to AMRN